Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

433.07
-20.6700-4.56%
Post-market: 433.300.2300+0.05%19:49 EDT
Volume:1.92M
Turnover:837.06M
Market Cap:109.88B
PE:28.27
High:452.00
Open:450.95
Low:431.01
Close:453.74
52wk High:510.77
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.38
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:5.89
PE(LYR):28.27

Loading ...

Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Oct 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Correspondence

Form CORRESP - Correspondence
May 05, 2025

Major Issues Report

Form 8-K - Current report
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities